• Mashup Score: 1

    Several biotechs and pharma companies have issued statements clarifying the impact of Saturday’s attacks in Israel on their workers and operations. Some of the first strikes, by land, sea and air, hit Tel Aviv and the outskirts of the capital, Jerusalem. That same afternoon, the militant group had launched at

    Tweet Tweets with this article
    • #Hamas strikes could impact some biopharma operations in #Israel. My @FINNPartners colleague @goeljasper offers analysis of how the threat of war may impact lifesaving #healthinnovation. https://t.co/jx9Vp9RWxk

  • Mashup Score: 0

    How can leaders improve health care equity for all? Explore issues and topics related to health equity across the health ecosystem.

    Tweet Tweets with this article
    • #WHISUSA is a wrap! Two days of great discussions, valuable networking, and sharing ideas to drive change in #WomensHealth through #HealthInnovation. Letโ€™s stay connected! https://t.co/FvSyGMgvkc https://t.co/ypUE1hEChL

  • Mashup Score: 0

    Gliomas are a complex group of brain and spinal cord tumors that start from glial cells, which are cells that support the health of the nervous system. Gliomas can range in severity, with the term high-grade gliomas often used to describe the most aggressive and dangerous forms of this cancer. High-grade gliomas are…

    Tweet Tweets with this article
    • Discover the future of glioma treatment with our in-depth article on the groundbreaking Ruxolitinib study. Get the latest insights on survival rates, treatment side effects, and expert opinions. #GliomaResearch #HealthInnovation #RuxolitinibBreakthrough https://t.co/g1Sm0OA44Z https://t.co/mtTSoHew1B

  • Mashup Score: 0

    Lavanya Vijayasingham and colleagues argue that as well as improving safety and efficacy, considering sex and gender related factors in medical research can have commercial benefits Earlier and stronger attention to sex and gender factors during medical product research and development, including vaccines, was widely called for by sex and gender experts before the covid-19 pandemic.12 A…

    Tweet Tweets with this article
    • ๐Ÿ”ฌ๐Ÿ’ฐ How can we bridge science & business for better health outcomes? Explore @lavanyav149 & co paper for insights on improving outcomes & commercial advantages. https://t.co/f8O6DtF6uz #DiversityandInclusion #HealthInnovation #WD2023 https://t.co/xtsiJDGYJw

  • Mashup Score: 0

    Fern Lazar, Managing Partner and Global Health Practice Leader at FINN Partners, was unanimously elected to the Cancer Research Instituteโ€™s Board of Trustees on July 11, 2023, at its quarterly meeting. Lazar is a senior strategist with over 30 years of experience in delivering high-energy creativity and advice backed knowledgeโ€ฆ

    Tweet Tweets with this article
    • .@fernlazar, @FinnPartners Global #Health Practice Leader, is unanimously elected to the @CancerResearch Board of Trustees. #healthinnovation #cancercare #PatientExperience https://t.co/TX58sKiGXA

  • Mashup Score: 0

    Lavanya Vijayasingham and colleagues argue that as well as improving safety and efficacy, considering sex and gender related factors in medical research can have commercial benefits Earlier and stronger attention to sex and gender factors during medical product research and development, including vaccines, was widely called for by sex and gender experts before the covid-19 pandemic.12 A…

    Tweet Tweets with this article
    • ๐Ÿ”ฌ๐Ÿ’ฐ Bridging science & business for better health outcomes. Explore @lavanyav149 & colleagues' paper for insights on improving outcomes & commercial advantages https://t.co/f8O6DtF6uz #DiversityandInclusion #HealthInnovation https://t.co/YELG7vgZhH